<p>iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma</p>
Author(s) -
Sulai Liu,
Jinqiong Jiang,
Linsheng Huang,
Yu Jiang,
Nanhui Yu,
Xiehong Liu,
Yuan Lv,
Hao Li,
Lianhong Zou,
Chuang Peng,
Xing Yu,
Bo Jiang
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s208773
Subject(s) - nitric oxide synthase , flow cytometry , apoptosis , gene knockdown , immunohistochemistry , cell cycle , cell growth , pathology , cancer research , cell , cell culture , biology , medicine , nitric oxide , microbiology and biotechnology , biochemistry , genetics
Inducible nitric oxide synthase (iNOS) has supposed to implicate in inflammation, infection, liver cirrhosis, and neoplastic diseases. This study was designed to explore the biological and clinical function of iNOS in intrahepatic cholangiocarcinoma (ICC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom